Home > Insider Trading > Filing (0001019056-13-001022)

Filing Details

Accession Number:: 0001019056-13-001022
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-09 18:15:20
Reporting Period:: 2013-06-15

Filing Date:: 2013-09-09
Accepted Time:: 2013-09-09 18:15:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1164426	Joseph Edelman	C/O Perceptive Advisors Llc 499 Park Avenue, 25Th Floor New York NY 10022	No	No	Yes	No
1224962	Perceptive Advisors Llc	499 Park Avenue 25Th Floor New York NY 10022	No	No	Yes	No
1249675	Ltd Fund Master Sciences Life Perceptive	C/O Perceptive Advisors Llc 499 Park Avenue, 25Th Floor New York NY 10022	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-15	100,000	$25.00	3,473,426	No	4	X	Indirect	See Footnotes
Common Stock	Acquisiton	2013-06-15	100,000	$25.00	3,573,426	No	4	X	Indirect	See Footnotes
Common Stock	Disposition	2013-09-05	700,000	$89.20	2,873,426	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-05	50,000	$89.20	2,823,426	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See Footnotes
No	4	X	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Call option (right to buy)	Disposition	2013-06-15	1,000	$0.00	100,000	$25.00
Common Stock	Call option (right to buy)	Disposition	2013-06-15	1,000	$0.00	100,000	$25.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,000	2013-06-15	2013-06-15	No	4	X	Indirect
0	2013-06-15	2013-06-15	No	4	X	Indirect

Footnotes

This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as investment manager to the Master Fund and to a managed account (the "Managed Account") for BioEdelman LLC, an entity directly owned by Mr. Edelman. Mr. Edelman is the managing member of the Advisor.
This transaction reflects the exercise of an in-the-money option by the Advisor on behalf of the Master Fund.
This transaction reflects the exercise of an in-the-money option by the Advisor on behalf of the Managed Account.
This transaction reflects the sale of securities by the Advisor on behalf of the Master Fund.
This transaction reflects the sale of securities by the Advisor on behalf of the Managed Account.
This amount reflects the total amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by the Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.